UnitedHealth seeking meeting with Trump as it faces regulatory challenges: report
UnitedHealth Seeks Meetings with President Trump Amid Regulatory Challenges
UnitedHealth has been actively seeking meetings with President Trump, as reported by the Wall Street Journal. Despite their efforts, a meeting has not been secured yet.
The top U.S. health insurer is ramping up its lobbying efforts in Washington, DC, in light of various regulatory challenges it is currently facing.
Among these challenges are high costs and federal investigations, including a criminal probe into its Medicare billing practices. These issues have led to a significant decrease in the company’s share price this year.
Stephen Hemsley, who recently returned to the CEO role, has been working to regain investor trust following the ouster of Andrew Witty earlier this year.
A recent meeting between Hemsley and Susie Wiles, Trump’s chief of staff, did not touch upon the ongoing criminal investigation, according to a White House official.
The discussions during the meeting reportedly covered topics related to the Medicare health insurance program for seniors and the disabled, as well as other relevant issues.
Hemsley also had a dinner meeting with Chris Klomp, who oversees Medicare, to discuss Medicare-plan billing policies and supplemental benefits offered under private Medicare plans.
UnitedHealth emphasized the importance of engaging with the administration and Congress to improve patient access and affordability amid critical decision-making processes.
A White House spokesperson highlighted that the Trump administration regularly meets with insurers to fulfill the President’s goal of enhancing healthcare and reducing costs for Americans.
